AbbVie Inc.
ABBV
$245.69
$1.890.78%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 419.86% | -61.73% | 876.34% | -80.17% | -27.06% |
| Total Depreciation and Amortization | -2.74% | -2.57% | -3.68% | 0.63% | 0.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -78.81% | 65.25% | -46.39% | 29.15% | 206.40% |
| Change in Net Operating Assets | -41.57% | -306.34% | -137.75% | 322.95% | 78.22% |
| Cash from Operations | -10.26% | -26.62% | -25.71% | 36.31% | 215.17% |
| Capital Expenditure | -21.51% | 19.45% | 13.65% | -41.64% | -14.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -209.77% | 77.09% | 58.57% | -198.09% | -74.72% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18.60% | -259.26% | 133.33% | -389.29% | -26.32% |
| Cash from Investing | -108.54% | 60.77% | 55.18% | -176.38% | -60.68% |
| Total Debt Issued | -100.00% | 1,698.20% | -307.47% | -93.92% | -29.07% |
| Total Debt Repaid | 19.97% | -212.77% | 60.37% | 46.30% | -24.06% |
| Issuance of Common Stock | -- | -- | -23.81% | -- | -- |
| Repurchase of Common Stock | 99.40% | -49,533.33% | 25.00% | 66.67% | 98.75% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.52% | -6.01% | 0.00% | -0.03% | 0.51% |
| Other Financing Activities | 1,150.00% | 300.00% | -102.70% | 1,133.33% | -95.52% |
| Cash from Financing | -649.95% | 122.06% | 9.24% | -69.37% | -115.42% |
| Foreign Exchange rate Adjustments | 41.67% | -209.09% | 237.50% | -126.67% | 233.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -167.80% | 1,140.50% | 52.27% | -164.86% | 470.20% |